US EditionHow to Find Safe Eye Drops Now That 75,000 Cases Were Just Recalled
- BRS Analytical Service, LLC voluntarily recalled multiple over-the-counter eye care products nationwide on May 12, 2025.
- The recall followed an FDA audit that identified current Good Manufacturing Practice deviations affecting product quality.
- The recall affects several eye care products, such as artificial tears and a 1% carboxymethylcellulose sodium gel, which have been distributed since May 26, 2023.
- AvKARE has called on stores to promptly stop selling these products and to take them out of their available stock, while advising consumers to cease using the items without delay.
- The deviations may cause unacceptable product quality, and it is not possible to rule out potential health risks to users from these products.
75 Articles
75 Articles
How proper nutrition can help protect your vision from glaucoma
Glaucoma is a leading cause of blindness in the United States and globally. Glaucoma is primarily caused by damage to the optic nerve, often due to pressure buildup in the eye, though other factors can contribute. Optic nerve damage can lead to vision loss and eventual blindness. The good news is that it’s possible to prevent or slow the progression of vision loss associated with glaucoma. Emerging science shows that nutrition plays a role in pr…
Artificial tears, other eye care products recalled after manufacturing ‘deviations’
An artificial tear solution is one of five ophthalmic products now under recall due to lapses in manufacturing processes, according to the FDA. The voluntary recalls were initiated by BRS Analytical Services following an FDA audit that revealed deviations from the agency’s current good manufacturing practice regulations and a “lack of assurance of sterility.” The products were
Coverage Details
Bias Distribution
- 78% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
